
Loading, please wait...

Loading, please wait...

Many adults aged 60 years or older take thyroid hormone medication for life. However, long-term use is not always necessary for everyone. A recent study investigated levothyroxine discontinuation in elderly patients. Researchers conducted a prospective trial involving 370 participants in the Netherlands. They aimed to determine who could safely stop treatment while maintaining normal thyroid function. These findings provide vital evidence for clinicians managing thyroid health in older populations.
Specifically, the study reported that 25.7% of participants successfully stopped taking levothyroxine. These individuals maintained stable thyrotropin (TSH) and free thyroxine (fT4) levels for one year. Notably, the success rate jumped to 63.6% for those taking a dose of 50 µg/day or lower. Furthermore, thyroid-related quality of life did not change significantly after stopping the drug. This suggests that many patients do not experience negative symptoms when they deprescribe thyroid hormones. Consequently, doctors should consider evaluating the need for ongoing therapy in older adults.
Moreover, the protocol involved a stepwise dose reduction rather than immediate cessation. This cautious approach ensures patient safety and allows for regular laboratory monitoring. Additionally, the study included community-dwelling adults who had stable dosages for at least one year. These results highlight a significant opportunity to reduce polypharmacy and avoid potential overtreatment. Therefore, clinicians should prioritize TSH evaluation for those on low-dose supplementation. Identifying suitable candidates for discontinuation can improve overall geriatric care and health outcomes.
No, discontinuation is not suitable for every patient. This study focused on adults 60 or older with stable low doses and TSH levels below 10 mIU/L. Always consult a physician before changing or stopping your dosage.
Patients on a levothyroxine dose of 50 µg/day or lower have a much higher success rate. In this trial, over 60% of those on low doses successfully stopped the medication without negative effects.
Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective study reveals that 25.7% of adults aged 60 or older can successfully discontinue levothyroxine, particularly those on low dosages (≤50 µg/d)....
3 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today